Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience

AstraZeneca plc

Cambridge (MA)

On-site

USD 100,000 - 120,000

Full time

14 days+

A complete application in a minute

Tailored resume and cover letter, ready to send.

Get past ATS filters

Job summary

AstraZeneca in Cambridge, MA is seeking a highly motivated postdoctoral fellow to join the Oncology Bioscience group. This role sits at the intersection of cancer biology and innate immunology, focusing on a first-in-class kinase inhibitor that may regulate tumor growth through innate immune engagement in multiple myeloma.

You will characterize the mechanism, identify the specific innate immune cell types responsible, and evaluate rational combinations with T-cell directed therapies, enabling

Qualifications

  • PhD awarded within four years or near completion with conferral within six months
  • Strong publication record with at least one first-author or co-first-author publication
  • Hands-on experience with in vivo mouse models, tumor implantation, and treatment studies
  • Proficiency in core molecular and cellular biology techniques: flow cytometry, CRISPR, western blot, ELISA, and functional assays
  • Background in hematological malignancies, particularly multiple myeloma
  • Strong scientific communication and data presentation skills

Responsibilities

  • Lead in vivo studies in mouse models to evaluate non-cancer cell autonomous effects of a first-in-class kinase inhibitor in multiple myeloma
  • Dissect innate immune cell contribution using CRISPR models, depletion, and reconstitution
  • Apply CyTOF, single-cell RNA-seq, and CITE-seq to map pathway modulation
  • Evaluate combination strategies with T-cell engagers and CAR-T therapies
  • Publish results with a first-author review in Year 1 and first-author manuscripts over three years

Skills

In vivo mouse models
CRISPR editing
Flow cytometry
Western blot
ELISA
Data interpretation
Scientific communication

Education

Ph.D. in Immunology, Hematology, Cancer Biology, Molecular or Cell Biology

Tools

CyTOF
CITE-seq
Single-cell RNA-seq
CRISPR cell line generation
Xenograft models (SCID/NSG)

Job description

Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience

Location: Cambridge, MA

AstraZeneca is seeking a highly motivated and scientifically rigorous postdoctoral fellow to join the Oncology Bioscience group in Cambridge. This position sits at the intersection of cancer biology and innate immunology, centered on a mechanistically novel discovery: that inhibition of a first-in-class kinase target can regulate tumor growth both through direct cell autonomous oncogenic signaling and non-cancer cell autonomous modulation of the innate immune system.

This work is built around a potent and selective first-in-class AstraZeneca compound, grounded in compelling preliminary in vivo data demonstrating that target inhibition drives tumor regression through innate immune engagement in multiple myeloma models. The postdoc will characterize this mechanism, identify the specific innate immune cell types responsible, and evaluate rational combination strategies with T-cell directed therapies.

This is a rare opportunity to lead a mechanistically novel program with direct translational relevance, publish in high-impact journals, and work alongside experts in oncology.

This postdoc role will report to Kayleigh Gallagher (Associate Principal Scientist) and be supported by Omid Tavana (Senior Director) at AstraZeneca.

Major Responsibilities
  • Lead in vivo studies in syngeneic and xenograft mouse models to establish and characterize the non-cancer cell autonomous function of a first-in-class kinase inhibitor in multiple myeloma
  • Dissect the mechanistic contribution of individual innate immune cell types through CRISPR-based models, immune cell depletion, and reconstitution experiments
  • Apply advanced immunophenotyping and transcriptomic platforms, including CyTOF, single-cell RNA-seq, and CITE-seq, to define pathway modulation across innate immune compartments
  • Evaluate rational combination strategies with T-cell engagers and CAR-T therapies in relevant preclinical models
  • Drive a clear publication plan, including a first-author review in Year 1 and a first-author research manuscripts over the three-year term
Minimum Requirements
  • Candidates must be within four years of receiving their doctoral degree (PhD, DVM or MD), with the PhD already awarded; or
  • Candidates who are nearing completion of their doctoral degree are eligible, provided the PhD is conferred within six months of joining AstraZeneca.
  • Education:Ph.D. in Immunology, Hematology, Cancer Biology, Molecular or Cell Biology, or a related field.
  • Training in a research-intensive academic laboratory with a strong publication record, including at least one first-author or co-first-author publication in a high-impact peer-reviewed journal
  • Hands-on experience with in vivo mouse models, including tumor implantation and treatment studies
  • Proficiency in core molecular and cellular biology techniques: flow cytometry, CRISPR cell line generation, western blot, ELISA, and cell-based functional assays
  • Background in hematological malignancies, particularly multiple myeloma
  • Strong scientific communication skills, with demonstrated ability to interpret and present complex datasets
Preferred Qualifications
  • Experience with xenograft mouse models (SCID, NSG) and immune cell depletion or reconstitution approaches
  • Familiarity with innate immune biology, including NK cell and macrophage biology
  • Exposure to advanced transcriptomic methods, including single-cell RNA-seq, CyTOF, or CITE-seq

Compensation for this role, based on years of experience after obtaining PhD, is a minimum of $99,900 up to a maximum of $120,000 + short-term incentive. Some relocation supplements depend on distance and location at the employer's discretion.

Why This Role

The postdoc will be embedded in a highly collaborative, multidisciplinary environment with direct access to internal experts in innate immunology, in vivo oncology, and clinical-stage hematology drug discovery. External mentorship will be provided by a leading investigator in the multiple myeloma field, offering additional scientific guidance and career development support. The program is supported by a fully resourced in vivo infrastructure, established assay platforms, and a clear publication roadmap.

About AstraZeneca

AstraZeneca is a global, science-led, patient-centered biopharmaceutical company focusing on discovering, developing, and commercializing prescription medicines for some of the world’s most serious diseases. But we’re more than a global leading pharmaceutical company. At AstraZeneca, we're dedicated to being a Great Place to Work and empowering employees to push the boundaries of science and fuel their entrepreneurial spirit.

AstraZeneca R&D Boston is a vibrant scientific community. The diverse make-up of our scientific teams, as well as our co-location with biotechs, results in a truly outstanding culture bursting with scientific innovation.

Where can I find out more?

AZ’s Postdoc Program: https://careers.astrazeneca.com/postdocs-astrazeneca

Life at AstraZeneca: https://careers.astrazeneca.com/life-at-astrazeneca

This is what we’re made of: https://www.youtube.com/watch?v=pmFx_jr2eFo&t=2s

Date Posted

03-Nov-2026

Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Postdoc Fellow, Multiple Myeloma Immuno-Oncology
Postdoc Fellow, Multiple Myeloma Immuno-Oncology

Jobtome • Cambridge (MA)

On-site
USD 100,000 - 120,000
Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience
Postdoctoral Fellow, Multiple Myeloma Immuno-Oncology, Oncology Bioscience

AstraZeneca plc • Cambridge (MA)

On-site
USD 100,000 - 120,000
Postdoc - Immune-Oncology in Multiple Myeloma
Postdoc - Immune-Oncology in Multiple Myeloma

Jobtome • Cambridge (MA)

On-site
USD 100,000 - 120,000
Postdoc: Immuno-Oncology in Multiple Myeloma
Postdoc: Immuno-Oncology in Multiple Myeloma

AstraZeneca plc • Cambridge (MA)

On-site
USD 100,000 - 120,000
Scientist, Immunology
Scientist, Immunology

AstraZeneca • Cambridge (MA)

On-site
USD 92,000 - 138,000
Postdoc in Myeloma Immuno-Oncology & Innate Immunity
Postdoc in Myeloma Immuno-Oncology & Innate Immunity

AstraZeneca plc • Cambridge (MA)

On-site
USD 100,000 - 120,000
Senior Director, Competitive Intelligence, Oncology R&D
Senior Director, Competitive Intelligence, Oncology R&D

AstraZeneca plc • Gaithersburg (MD)

On-site
USD 218,000 - 327,000
Short-term incentives
Equity-based awards
Commissions
+3
Senior Global Development Scientist, Director
Senior Global Development Scientist, Director

AstraZeneca plc • Gaithersburg (MD)

Hybrid
USD 234,000 - 350,000
Senior Scientist - Drug Discovery (AI/ML)
Senior Scientist - Drug Discovery (AI/ML)

AstraZeneca plc • Gaithersburg (MD)

On-site
USD 119,000 - 178,000
Global Clinical Program Lead, Hematology
Global Clinical Program Lead, Hematology

AstraZeneca plc • Gaithersburg (MD)

Hybrid
USD 288,000 - 432,000